Daniel Harris Email

VP Pharmaceutical Development and CMC at Lumicell . Lumicell

Current Roles

Employees:
66
Revenue:
$8.3M
About
Lumicell is a leader in the field of image-guided cancer surgery. Lumicell technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett's Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.
Lumicell Address
One Newton Place, 275 Washington St.
Wellesley, MA
United States
Lumicell Email

Past Companies

LumicellVice President of Pharmaceutical Development and CMC at Lumicell
LumicellSenior Director of Drug Manufacturing
LumicellDirector of Drug Manufacturing and Supply Chain

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.